AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $3.897M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 03/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 5.0¢ | Day High | 5.0¢ | Day Low | 5.0¢ | |||
| Daily Volume | 22405 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 5.0¢ | 3044 | 0 | 5.5¢ | 45125 | |
Directors & Senior Management
| Mr. Ben Robinson | Head of Growth |
| Mr. Brook Adcock | Interim Chair |
| Mr. James Aulsebrook | Chief Financial Officer |
| Mr. Joshua Luke Mundey | CEO, MD & Director |
| Ms. Maria Clemente | Company Secretary |
| Mr. Michael Kafrouni | COO & Executive Director |
Data source: ADVFN
